Synmosa Biopharma Corporation replaced Fan, De-Quan as Independent Director of the company with Wang Chien-Jen, effective date is May 25, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.05 TWD | +0.25% | +0.75% | +3.62% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.62% | 473M | |
+42.60% | 748B | |
+33.81% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+17.19% | 245B | |
+9.34% | 211B | |
-3.93% | 209B | |
+1.81% | 166B |
- Stock Market
- Equities
- 4114 Stock
- News Synmosa Biopharma Corporation
- Synmosa Biopharma Corporation Announces Wang Chien-Jen as Independent Director